BUSINESS Pfizer increases 2021 sales forecast for COVID-19 vaccines to $26 bn

BUSINESS

Pfizer increases 2021 sales forecast for COVID-19 vaccines to $26 bn

AFP

19:31, May 04, 2021

This April 15, 2021, file photo syringes filled with the Pfizer COVID-19 vaccine are shown at the Christine E. Lynn Rehabilitation center in Jackson Memorial hospital in Miami. (Photo: AP)

Pfizer sharply increased its projections for 2021 revenues and profits on Tuesday, citing much higher sales from its COVID-19 vaccine sales.

The drugmaker now estimates 2021 revenues of $26 billion from the vaccine, up from $15 billion previously. Pfizer sees profits of between $3.55 and $3.65 per share, up 45 cents from the previous range.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue